European Journal of Cancer
Издатель: Elsevier · ISSN 0959-8049 · 68 статей
- Response to Letter Re: A stromal-immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study
- Letter re: “diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis"
- Corrigendum to “MRI in advanced ovarian cancer: Multicentre MISSION trial” [Eur J Cancer 238 (2026) 116614]
- Corrigendum to “Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations” Eur J Cancer 226 (August) (2025) 115591
- Corrigendum to “Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service” [Eur J Cancer 246 (October) (2026) 116981]
- Outcomes of CD20-targeting CAR T-cell therapy in patients with advanced melanoma: MB-CART20.1 Melanoma phase I trial
- Acute and long-term outcomes of CD20-targeting CAR T-cell therapy in relapsed or refractory B-NHL: MB-CART20.1 Lymphoma phase I trial
- A new era in anti-RAS therapy: Unique challenges and opportunities for radiotherapy clinical trials
- Drugging the luminal axis end to end: A review of next-generation endocrine and targeted therapies in HR + /HER2- metastatic breast cancer
- From staging to changing strategy: [18F]FDG PET/MRI’s impact on treatment planning in early breast cancer
- Risk stratification and potential overtreatment in adjuvant CDK4/6 inhibitor trials: do all patients with Stage II disease and favorable biology derive benefit?
- PELICAN-IPC 2015–016/Oncodistinct-003: A randomized non-comparative phase II study of pembrolizumab in combination with neoadjuvant chemotherapy in HER2-negative inflammatory breast cancer
- Diagnostic challenges in WHO classification of thymic epithelial tumors: The clinical value of an international expert pathology panel
- Radical local treatment for patients with NSCLC following oligoprogression after chemoradiation and durvalumab
- Circulating tumor DNA-guided therapeutic strategies for metastatic colorectal cancer patients with multiple small pulmonary-limited nodules: A prospective cohort study
- Novel adenoma-immune phenotypes are associated with risk of metachronous polyps and colorectal cancer in a bowel screening cohort
- Mapping the overlap of predictive biomarkers in an advanced Austrian multicenter gastroesophageal adenocarcinoma real-world cohort - results from the AGMT GASTRIC-5 registry
- Factors associated with chemotherapy free interval (CFI) after induction chemotherapy in metastatic colorectal cancer (mCRC) based on a meta-analysis on ARCAD CRC database: The CFI-SCORE project
- Preventing progression to reduce costs: A cost-effectiveness analysis of enfortumab vedotin+pembrolizumab in MIBC
- "HPV16 circulating tumour DNA for prognostic stratification and post-treatment surveillance in HPV-positive oropharyngeal cancer: A multinational study"
- Radiation-induced brain necrosis among patients with nasopharyngeal cancer treated with proton vs photon radiotherapy
- Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM)
- Osteosarcoma as a second or later malignancy: Presentation, treatment, and survival of 198 patients from the Cooperative Osteosarcoma Study Group
- Cytokine release syndrome across three immunotherapy platforms: A real-world patient-level comparison of CAR T-cell, T-cell engager, and immune checkpoint inhibitor therapies
- Efficacy and safety of chimeric antigen receptor T-cell therapy versus standard treatment in hemato-oncology: A systematic review and meta-analysis
- A health-related quality of life measurement strategy for solid rare cancers: Primary findings from the EORTC Quality of Life Group (QLG) QoL Rare Cancer Study
- Risk factors for early-onset cancers: Results from the JANUS cohort in Norway
- Liver cancer incidence trends in younger versus older adults over time: an analysis of population-based cancer registry data
- Vitamin D supplementation, cancer incidence and mortality: Randomized trials revisited
- DNA methylation-based immune profiling reveals distinct subtypes in esophageal adenocarcinoma